Retatrutide Early Access has started for a limited group of patients before its expected FDA approval. Eli Lilly has launched an expanded access program for eligible adults with severe obesity.
Moderna has beaten Wall Street revenue estimates just days before a major US regulatory decision. The quarterly revenue surprise comes as the company prepares for the FDA's verdict on its flu vaccine.
Cancer drug development drives Glenmark’s next phase of global expansion, the company targets USD 600 million revenue from new oncology launches
Strong Business, Indegene, Q1 FY27, operating revenue, net profit, EBITDA, EBITDA margin, active clients, Gen AI, pharmaceutical services, healthcare technology, revenue growth
Patients with Heart Failure often need hospital visits when fluid builds up in the body. MannKind now wants to change that with its Autoinjector Pen technology. The company is developing a treatment that could replace IV infusions with a quick...
Indian drugmaker Alembic Pharma has expanded its US portfolio with USFDA approval for generic constipation treatment.
Relopduo has officially entered the Indian market. The launch marks another step in strengthening cancer treatment options.
India’s rapid healthcare expansion highlights the urgent need to ensure that growth translates into making healthcare affordable for a larger population
Roche has reaffirmed its full-year guidance, keeping Roche's Growth Story alive despite Vabysmo slowdown sales and ongoing currency headwinds.
The 6th Edition Drug Safety Symposium 2026 – India Chapter, organized by Eminence Business Media, concluded successfully in Mumbai, reaffirming its position as one of India's leading knowledge
.jpg)
, CDSCO.jpg)